Clincosm LogoSign in Get a demo

myelogenous leukemia

Showing 1 - 4 of 4
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Innate CD8+ T Cells and Evolution of Tyrosine Kinase Inhibitor

Recruiting
  • Leukemia
  • +3 more
  • Phenotyping of total and innate CD8+T cells by flow cytometry
  • Nîmes, Gard, France
    CHU de Nîmes
Jul 19, 2021

Multiple Myeloma, Non-Hodgkin's Lymphoma, Hodgkin's Disease Trial in Boston (Tacrolimus, Sirolimus, G-CSF)

Completed
  • Multiple Myeloma
  • +4 more
  • Boston, Massachusetts
  • +1 more
Jul 22, 2016

Hematologic Malignancies, Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Boston (Sirolimus, Tacrolimus)

Completed
  • Hematologic Malignancies
  • +5 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 24, 2012

Myelogenous Leukemia Trial in Worldwide (Imatinib, Nilotinib (AMN107))

Terminated
Has Results
  • Myelogenous Leukemia
  • Tucson, Arizona
  • +79 more
Nov 4, 2011